Diaryl substituted pyrazoles as potent CCR2 receptor antagonists
Authors:
- Anthony B. PinkertonAPAnthony B. Pinkerton
- Dehua HuangDHDehua Huang
- Rowena V. CubeRCRowena V. Cube
- John H. HutchinsonJHJohn H. Hutchinson
- Mary StruthersMSMary Struthers
- Julia M. AyalaJAJulia M. Ayala
- Pasquale P. VicarioPVPasquale P. Vicario
- Sima R. PatelSPSima R. Patel
- Thomas WisniewskiTWThomas Wisniewski
- Julie A. DeMartinoJDJulie A. DeMartino
- Jean-Michel VernierJVJean-Michel Vernier
- 1 February 2007
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 17 (3) , 807-813
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Chemokines: more than just road signsNature Reviews Immunology, 2006
- The CCR2 receptor as a therapeutic targetExpert Opinion on Therapeutic Patents, 2005
- Recent developments in modulating chemokine networksExpert Opinion on Therapeutic Patents, 1999
- Opportunities for novel therapeutic agents acting at chemokine receptorsDrug Discovery Today, 1999
- Chemokines: understanding their role in T-lymphocyte biologyBiochemical Journal, 1998
- Abnormalities in Monocyte Recruitment and Cytokine Expression in Monocyte Chemoattractant Protein 1–deficient MiceJournal of Experimental Medicine, 1998
- Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2Proceedings of the National Academy of Sciences, 1997
- Human Chemokines: An UpdateAnnual Review of Immunology, 1997
- Cloning and characterization of human chemokine receptorsTrends in Pharmacological Sciences, 1996
- Molecular cloning and functional expression of two monocyte chemoattractant protein 1 receptors reveals alternative splicing of the carboxyl-terminal tails.Proceedings of the National Academy of Sciences, 1994